Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience | Zendy

Prabhat Bhargava | Zendy; Narmadha Rathnasamy | Zendy; Ramnath Shenoy | Zendy; Seema Gulia | Zendy; Jyoti Bajpai | Zendy; Jaya Ghosh | Zendy; Sushmita Rath | Zendy; Ashwini Budrukkar | Zendy; Tanuja Shet | Zendy; Asawari Patil | Zendy; Sangeeta Desai | Zendy; Nita Nair | Zendy; Shalaka Joshi | Zendy; Palak Popat | Zendy; Tabassum Wadasadawala | Zendy; Rima Pathak | Zendy; Rajiv Sarin | Zendy; Sadhana Kannan | Zendy; Rajendra Badwe | Zendy; Sudeep Gupta | Zendy

Open Access

Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience

Author(s) -

Prabhat Bhargava,

Narmadha Rathnasamy,

Ramnath Shenoy,

Seema Gulia,

Jyoti Bajpai,

Jaya Ghosh,

Sushmita Rath,

Ashwini Budrukkar,

Tanuja Shet,

Asawari Patil,

Sangeeta Desai,

Nita Nair,

Shalaka Joshi,

Palak Popat,

Tabassum Wadasadawala,

Rima Pathak,

Rajiv Sarin,

Sadhana Kannan,

Rajendra Badwe,

Sudeep Gupta

Publication year - 2022

Publication title -

jco global oncology

Language(s) - English

Resource type - Journals

ISSN - 2687-8941

DOI - 10.1200/go.22.00126

Subject(s) - lapatinib , medicine , trastuzumab , brain metastasis , trastuzumab emtansine , oncology , metastatic breast cancer , breast cancer , interquartile range , targeted therapy , cancer , cohort , radiation therapy , retrospective cohort study , hazard ratio , metastasis , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research